Paper Details

  1. Home
  2. Paper Details

Anticholinergic medications for reducing drooling in children with developmental disability.

Author: GuzysAngela T, ReddihoughDinah S, ReidSusan M, WestburyChristine

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study aimed to determine the effectiveness of three anticholinergic medications in reducing drooling in children with developmental disabilities, the frequency and nature of side effects, and their impact on treatment discontinuation.
Paper Details　
Original Abstract of the Article :
To determine: the effectiveness of three anticholinergic medications in reducing drooling in children with developmental disabilities (such as cerebral palsy, intellectual disability, and autism spectrum disorder), the frequency and nature of side effects, and their impact on treatment discontinuati...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/dmcn.14350

データ提供：米国国立医学図書館（NLM）

Anticholinergic Medications for Drooling in Children with Developmental Disabilities

Drooling, a common issue in children with developmental disabilities, can be a challenging and often embarrassing problem. This research explores the potential of anticholinergic medications, a group of drugs that block the effects of acetylcholine, as a potential solution for reducing drooling in this vulnerable population.

Navigating the Complexities of Anticholinergic Treatment

The researchers, like skilled navigators in a vast and intricate desert, sought to understand the effectiveness and safety of anticholinergic medications for treating drooling in children with developmental disabilities. Their study examined the efficacy of three different anticholinergic medications and their impact on drooling, side effects, and treatment discontinuation.

A Search for Solutions in a Challenging Terrain

The findings of this study offer valuable insights into the potential benefits and drawbacks of anticholinergic medications for treating drooling in children with developmental disabilities. It's like navigating a challenging desert landscape, where the path to success can be fraught with obstacles. While the study found that these medications can be effective in reducing drooling, it also highlighted the importance of careful monitoring for potential side effects and tailoring treatment to the individual needs of each child.

Dr. Camel's Conclusion

This study provides valuable information for healthcare providers treating children with developmental disabilities and excessive drooling. It's like finding a map through a complex and challenging desert landscape, offering guidance and support in navigating this often difficult terrain.
Date :
  1. Date Completed 2020-05-05
  2. Date Revised 2020-05-05
Further Info :

Pubmed ID

31495925

DOI: Digital Object Identifier

10.1111/dmcn.14350

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.